Hyperhomocysteinemia: A risk factor for ischemic stroke in children

Circulation

Volumn 99, Issue 16, 1999, Pages 2070-2072

  Van Beynum, Ingrid M ^b   Smeitink, Jan A M ^b   Den Heijer, Martin ^b   Te Poele Pothoff, Maria T W B ^b   Blom, Henk J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Cerebral infarction; Hyperhomocysteinemia; Pediatrics; Stroke

Indexed keywords

ADOLESCENT; ARTERY DISEASE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; INFANT; MALE; NETHERLANDS; NEWBORN; PRIORITY JOURNAL; RISK FACTOR; STROKE; VEIN THROMBOSIS;

EID: 0033609098     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.16.2070     Document Type: Article

References (13)

1. Broderick J, Talbot GT, Prenger E, Leach A, Brott T. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol. 1993;8:250-255.
2. Nicolaides P, Appleton RE. Stroke in children. Dev Med Child Neurol. 1996;38:172-180.
3. Mancini J, Girard N, Chabrol B. Ischemic cerebrovascular disease in children: retrospective study of 35 patients. J Child Neurol. 1997;12: 193-199.
4. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GHJ, Bromberg IL, Cerone R, Fowler B, Gröbe H, Schmidt H, Schweitzer L. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985;37:1-31.
5. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA. 1995;274:1049-1057.
6. Selhub J, Jaques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ, O'Leary DH, Wolf PA, Schaeffer EJ, Rosenberg IH. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;268:877-881.
7. den Heijer M, Koster T, Blom HJ, Bos GMJ, Briët E, Reitsma PH, Vandenbroucke JP, Rosendaal FR. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759-762.
8. Poele-Pothoff MTWB, van der Berg M, Franken DG, Boers GHJ, Jakobs C, Kroon IFI, Eskes TKAB, Trijbels JMF, Blom HJ. Three different methods for determination of total homocysteine in plasma. Ann Clin Biochem. 1995;32:218-220.
9. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease and drug therapy. J Lab Clin Med. 1989;114:473-501.
10. Schneede J, Dagnelie PC, van Staveren WA, Vollset SE, Refsum H, Ueland PM. Methylmalonic acid and homocysteine in plasma as indicators of functional cobalamin deficiency in infants on macrobiotics diets. Pediatr Res. 1994;36:194-201.
11. Refsum H, Wesenberg F, Ueland PM. Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate. Cancer Res. 1991;51:828-835.
12. Tonstad S, Refsum H, Sivertsen M, Christophersen B, Ose L, Ueland PM. Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives. Pediatr Res. 1996;40:47-52.
13. Vilaseca MA, Moyano D, Artuch R, Ferrer I, Pineda M, Cardo E, Campistol J, Pavia C, Camacho JA. Selective screening for hyperhomocysteinemia in pediatric patients [Technical Brief]. Clin Chem. 1998;44:662-664.